Alibaba Health Information Technology (HKG:0241) recorded a rise in attributable profit for the year ended March 31 to 1.43 billion yuan from 883.5 million yuan a year prior, a Monday filing with the Hong Kong bourse said.
Earnings per share stood at 0.0888 yuan for the year, down from 0.0627 yuan in the corresponding period of the last fiscal year.
Revenue for the internet solutions provider for the medical and pharmaceutical sector rose by 13% to 30.6 billion yuan in the period from 27 billion yuan a year prior.
The higher revenue was mainly due to the steady development of the pharmaceutical direct sales and ecommerce platform businesses.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.